Join us and Muscular Dystrophy Canada at our next #Neuromuscular Mystery Case Rounds, a CPD-accredited webinar led by Dr. Altaher Alfaez, Neuromuscular Clinical Fellow (@westernu.ca) Register: bit.ly/NMRoundsSept... 📅 Tue September 1, 2025 🕔️ 6:00-7:00pm ET #LetsTalkNMD #nmd #neuromuscularmedicine

Have questions about disability protections and #myotonicDystrophy?💚 Join our Ask the Expert webinar with Disability Justice Advocate, Marisa Spain, to learn about self-advocacy strategies and work accommodations. 💬🔗Register at: events.zoom.us/ev/Ahsp1Eq1i...

We are happy to announce that the “8th Ottawa International Conference On Neuromuscular Disease & Biology” #OttawaNMD2027 will be held on October 14-16, 2027 at the Chateau Laurier in Ottawa, Ontario, Canada! For questions and to be notified when registration opens, please contact cpd@uottawa.ca

New SOP from @nmd4c.ca Basic Science Trainee Committee! Shatha Atieh (#BSTC) has released a standard operating procedure (SOP) for skeletal muscle fiber typing and CSA analysis using immunofluorescence. Read more about our neuromuscular SOPs on our website: neuromuscularnetwork.ca/news/introdu...

Introducing Our New SOP on Skeletal Muscle Fiber Typing - News- NMD4C

We are excited to announce the release of our latest Standard Operating Procedure (SOP) titled “Skeletal Muscle Fiber Typing & Cross-Sectional Area Analysis using Immunofluorescence Staining for Mice,...

neuromuscularnetwork.ca

Join our next Community of Practice Sharing Session for Canadian PT’s & OT’s who see #neuromuscular patients Topic: Respiratory Health & Treatments for #DMD & #SMA Presenter: Cheryl Scholtes, Physiotherapist, LHSC Date: 17 September 2026 Time: 2PM ET Register: neuromuscularnetwork.ca/pt-ot-09-2026

Physiotherapy and Occupational Therapy Community of Practice Knowledge Sharing Session – Respiratory Health and Treatments for DMD and SMA presented - Events - NMD4C

Speaker: Cheryl Scholtes, PT

neuromuscularnetwork.ca

Join our next Community of Practice Sharing Session for Clinical Trial Personnel on "Canadian #ClinicalTrial Startups: Critical Local Considerations and Risk Reduction" • Presenter: Janet Petrillo Ballantyne • Date: 15 September 2026 • Time: 1PM ET Register: neuromuscularnetwork.ca/ctp-09-2026

Physiotherapy and Occupational Therapy Community of Practice Knowledge Sharing Session – Respiratory Health and Treatments for DMD and SMA presented - Events - NMD4C

Speaker: Cheryl Scholtes, PT

neuromuscularnetwork.ca

Join our next Community of Practice Sharing Session for Clinical Trial Personnel on "Canadian #ClinicalTrial Startups: Critical Local Considerations and Risk Reduction" • Presenter: Janet Petrillo Ballantyne • Date: 15 September 2026 • Time: 1PM ET Register: neuromuscularnetwork.ca/ctp-09-2026

Physiotherapy and Occupational Therapy Community of Practice Knowledge Sharing Session – Respiratory Health and Treatments for DMD and SMA presented - Events - NMD4C

Speaker: Cheryl Scholtes, PT

neuromuscularnetwork.ca

Join our next Community of Practice Sharing Session for Canadian PT’s & OT’s who see #neuromuscular patients Topic: Respiratory Health & Treatments for #DMD & #SMA Presenter: Cheryl Scholtes, Physiotherapist, LHSC Date: 17 September 2026 Time: 2PM ET Register: neuromuscularnetwork.ca/pt-ot-09-2026

Physiotherapy and Occupational Therapy Community of Practice Knowledge Sharing Session – Respiratory Health and Treatments for DMD and SMA presented - Events - NMD4C

Speaker: Cheryl Scholtes, PT

neuromuscularnetwork.ca

Defeat Duchenne Canada is recognizing outstanding family and clinician volunteers in the Duchenne Community! Know someone who deserves recognition? Submit a nomination today. Self-nominations are welcome: docs.google.com/forms/d/e/1F...

We are happy to announce that the “8th Ottawa International Conference On Neuromuscular Disease & Biology” #OttawaNMD2027 will be held on October 14-16, 2027 at the Chateau Laurier in Ottawa, Ontario, Canada! For questions and to be notified when registration opens, please contact cpd@uottawa.ca

📊 New research powered by the #MyotonicDystrophy community! Data from 1,744 Myotonic Dystrophy Family Registry participants highlight 5 findings about how DM1 and DM2 affect daily life. Thank you to everyone helping deepen our understanding of DM! 💚 myotonic.org/myotonic-dys...

New SOP from @nmd4c.ca Basic Science Trainee Committee! Shatha Atieh (#BSTC) has released a standard operating procedure (SOP) for skeletal muscle fiber typing and CSA analysis using immunofluorescence. Read more about our neuromuscular SOPs on our website: neuromuscularnetwork.ca/news/introdu...

Introducing Our New SOP on Skeletal Muscle Fiber Typing - News- NMD4C

We are excited to announce the release of our latest Standard Operating Procedure (SOP) titled “Skeletal Muscle Fiber Typing & Cross-Sectional Area Analysis using Immunofluorescence Staining for Mice,...

neuromuscularnetwork.ca

Our July 2026 NMD4C newsletter is now available with the latest updates from across Canada’s #neuromuscular community. 🔗 | Read it on our website: lnkd.in/gkzcVKJM #NeuromuscularResearch #NMDresearch #MedicalResearch #ECR #TranslationalResearch #ClinicalResearch #CanadaResearch #RareDiseases

1/2 | Happy Canada Day🇨🇦 Today we celebrate collaboration that strengthens neuromuscular research & care across Canada. Our work reflects a shared commitment to connecting expertise, advancing #neuromuscular research, improving care and supporting the next generation of NMD scientists and clinicians

1/2 | Happy Canada Day🇨🇦 Today we celebrate collaboration that strengthens neuromuscular research & care across Canada. Our work reflects a shared commitment to connecting expertise, advancing #neuromuscular research, improving care and supporting the next generation of NMD scientists and clinicians

Registration is now open for the 2026 LGMD Scientific Summit, hosted by The Speak Foundation Date: Friday, July 31, 2026 Time: 11:00 AM to 3:00 PM EDT Format: Virtual 🔗 Register here: lp.constantcontactpages.com/ev/reg/md2vj6u #LGMD #MuscularDystrophy #ClinicalTrials #RareDisease #MedicalResearch

From June 8–10, we hosted our 3rd annual NMD4C Basic Research Summer School at @uottawa.ca for #neuromuscular trainees. 🧪 We would like to thank all 28 trainees who came from across Canada for their thoughtful participation & contributions. 🇨🇦 🔗 Read full article neuromuscularnetwork.ca?p=205660

NMD4C Hosts 3rd Annual Basic Research Summer School at uOttawa! - News - NMD4C

From June 8 to 10, 2026, we hosted the 3rd annual NMD4C Basic Research Summer School at the University of Ottawa. The program supported 28 neuromuscular research trainees (graduate students and postdo...

neuromuscularnetwork.ca

From June 8–10, we hosted our 3rd annual NMD4C Basic Research Summer School at @uottawa.ca for #neuromuscular trainees. 🧪 We would like to thank all 28 trainees who came from across Canada for their thoughtful participation & contributions. 🇨🇦 🔗 Read full article neuromuscularnetwork.ca?p=205660

NMD4C Hosts 3rd Annual Basic Research Summer School at uOttawa! - News - NMD4C

From June 8 to 10, 2026, we hosted the 3rd annual NMD4C Basic Research Summer School at the University of Ottawa. The program supported 28 neuromuscular research trainees (graduate students and postdo...

neuromuscularnetwork.ca

@nmd4c.ca and Muscular Dystrophy Canada are pleased to invite you to today's CPD-accredited webinar, focused on Emerging Biomarkers in Spinal Muscular Atrophy led by Hugh McMillan, MD, MSc, FRCPC (Chair) and Charlotte René. 🔗 Register here: bit.ly/SMABiomarker... 📅 16th June, 2026 🕔️ 5:00–6:00 pm ET

The NMD4C June 2026 Newsletter is now live! neuromuscularnetwork.ca/06-2026 Explore new research, funding calls, training opportunities, webinars, and community updates shaping neuromuscular care in Canada.

Canadian led phase II studies in boys with DMD supported approval of vamorolone, the first #DMD treatment in Canada. Dr. Jean Mah noted expanded clinical experience, and Nicola Worsfold of Defeat Duchenne Canada highlighted the importance of national collaboration: neuromuscularnetwork.ca?p=205547

Congratulations to NMD4C-BSTC 2026 Image Competition winners: 🥇 Madison Garibotti, PhD Candidate, York University 🥈 Dr. Tatiana Koike, Postdoctoral Fellow, CHU Sainte-Justine & Université de Montréal 🥉 Alexa Derksen, PhD Candidate, UOttawa & CHEO RI Gallery: neuromuscularnetwork.ca/Competition-...

The AFC in Neuromuscular Medicine is progressing toward national program accreditation, with PGME teams now preparing applications. Join us for an AFC workshop at the NMD4C Investigator Meeting on Sept 25. More info: neuromuscularnetwork.ca/news/afc-in-...

We’re happy to share NMD4C Clinical Trial Network’s new publication on building a coordinated Canadian approach to strengthen neuromuscular trial readiness, capacity, and access. It outlines key barriers and practical strategies for rare disease trials. Read it here: pubmed.ncbi.nlm.nih.gov/42192450

We’re happy to share NMD4C Clinical Trial Network’s new publication on building a coordinated Canadian approach to strengthen neuromuscular trial readiness, capacity, and access. It outlines key barriers and practical strategies for rare disease trials. Read it here: pubmed.ncbi.nlm.nih.gov/42192450

The AFC in Neuromuscular Medicine is progressing toward national program accreditation, with PGME teams now preparing applications. Join us for an AFC workshop at the NMD4C Investigator Meeting on Sept 25. More info: neuromuscularnetwork.ca/news/afc-in-...

NMD4C Collaborative Research Training Awards close in under 2 weeks! MSc/PhD student, postdoctoral fellow #ECR or a #neuromuscular research professional, this program offers hands on experience and collaboration across Canada Apply by June 15, 2026: neuromuscularnetwork.ca/pillar-1-pre...

Congratulations to NMD4C-BSTC 2026 Image Competition winners: 🥇 Madison Garibotti, PhD Candidate, York University 🥈 Dr. Tatiana Koike, Postdoctoral Fellow, CHU Sainte-Justine & Université de Montréal 🥉 Alexa Derksen, PhD Candidate, UOttawa & CHEO RI Gallery: neuromuscularnetwork.ca/Competition-...

Canadian led phase II studies in boys with DMD supported approval of vamorolone, the first #DMD treatment in Canada. Dr. Jean Mah noted expanded clinical experience, and Nicola Worsfold of Defeat Duchenne Canada highlighted the importance of national collaboration: neuromuscularnetwork.ca?p=205547

The NMD4C June 2026 Newsletter is now live! neuromuscularnetwork.ca/06-2026 Explore new research, funding calls, training opportunities, webinars, and community updates shaping neuromuscular care in Canada.